Potential role of P-gp for flavone-induced diminished apoptosis and increased adenoma size in the small intestine of APCmin/+ mice

Cancer Investigation

Volumn 29, Issue 6, 2011, Pages 396-404

  Schumacher, Marco ^a   Hautzinger, Anja ^a   Rossmann, Annette ^a   Holzhauser, Susanne ^a   Popovic, Daniela ^a   Hertrampf, Anke ^a   Oesterle, Doris ^b   Spiller, Carmen ^b   Boll, Michael ^a   Wenzel, Uwe ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Adenomatous polyposis coli; Apoptosis; Cleaved caspase; Flavone; Phosphoglycoprotein 170

Indexed keywords

APC PROTEIN; CASPASE 3; FLAVONE; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN;

APOPTOSIS; ARTICLE; CELL COUNT; CELL STRAIN CACO 2; CONTROLLED STUDY; ENZYME METABOLISM; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; INTESTINE POLYP; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN VARIANT; SMALL INTESTINE; TUMOR VOLUME;

ADENOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; APOPTOSIS; BETA CATENIN; CACO-2 CELLS; FEMALE; FLAVONES; GENES, APC; HUMANS; ILEUM; INTESTINAL NEOPLASMS; JEJUNUM; MALE; MICE; MICE, INBRED C57BL; P-GLYCOPROTEIN;

EID: 79958232077     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2011.587071     Document Type: Article

References (36)

1. Kwong LN, Dove WF. APC and its modifiers in colon cancer. Adv Exp Med Biol 2009;656:85-106.
2. Benchabane H, Ahmed Y.The adenomatous polyposis coli tumor suppressor and Wnt signaling in the regulation of apoptosis. Adv Exp Med Biol 2009;656:75-84.
3. Phelps RA, Broadbent TJ, StafforiniDM, JonesDA. Newperspectives on APC control of cell fate and proliferation in colorectal cancer. Cell Cycle 2009;8:2549-2556.
4. Shitashige M, Hirohashi S, Yamada T. Wnt signaling inside the nucleus. Cancer Sci 2008;99:631-637. (Pubitemid 351448063)
5. Yamada T, Takaoka AS, Naishiro Y, Hayashi R, Maruyama K, Maesawa C, Ochiai A, Hirohashi S. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Cancer Res 2000;60:4761-4766.
6. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493-501.
7. Smyth MJ, Krasovskis E, Sutton VR, Johnstone RW. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc Natl Acad Sci 1998;95:7024-7029.
8. Linn SC, Giaccone G. MDR1/P-glycoprotein expression in colorectal cancer. Eur J Cancer 1995;31A:1291-1294.
9. Yamada T, Mori Y, Hayashi R, Takada M, Ino Y, Naishiro Y, Kondo T, Hirohashi S. Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice. Cancer Res 2003;63:895-901. (Pubitemid 36278415)
10. Herzog A, Kindermann B, Döring F, Daniel H, Wenzel U. Pleiotropic molecular effects of the pro-apoptotic dietary constituent flavone in human colon cancer cells identified by protein and mRNA expression profiling. Proteomics 2004;4:2455-2464. (Pubitemid 39025346)
11. Herzog A, Kuntz S, Daniel H, Wenzel U. Identification of biomarkers for the initiation of apoptosis in human preneoplastic colonocytes by proteome analysis. Int J Cancer 2004;109:220-229. (Pubitemid 38240924)
12. Winkelmann I, Diehl D, Oesterle D, Daniel H, Wenzel U. The suppression of aberrant crypt multiplicity in colonic tissue of 1,2- dimethylhydrazine-treated C57BL/6J mice by dietary flavone is associated with an increased expression of Krebs cycle enzymes. Carcinogenesis 2007;28:1446-1454. (Pubitemid 47241794)
13. Winkelmann I,Diehl D, Oesterle D, Daniel D, Wenzel U. Flavone induces changes in intermediary metabolism that prevent microadenoma formation in colonic tissue of carcinogen-treated mice. Mol Nutr Food Res 2010;54:S184-S195.
14. Wenzel U, Schoberl K, Lohner K, Daniel H. Activation of mitochondrial lactate uptake by flavone-induced apoptosis in human colon cancer cells. J Cell Physiol 2005;202:379-390. (Pubitemid 40041308)
15. Schagger H, von Jagow G. Tricine-sodium dodecyl sulfatepolyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987;166:368-379. (Pubitemid 18004907)
16. van der Sandt IC, Blom-Roosemalen MC, de Boer AG, Breimer DD. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines. Eur J Pharm Sci 2000;11:207-214. (Pubitemid 30616443)
17. Li H, Jin HE, Kim W, Han YH, Kim DD, Chung, SJ, Shim, CK. Involvement of P-glycoprotein, multi-drug resistance protein 2 and breast cancer resistance protein in the transport of belotecan and topotecan in Caco-2 and MDCKII cells. Pharm Res 2008;25:2601-2612.
18. Gryczynski I, Gryczynski Z, Lakowicz JR, Yang D, Burke TG. Fluorescence spectral properties of the anticancer drug topotecan by steady-state and frequency domain fluorometry with one-photon and multi-photon excitation. Photochem Photobiol 1999;69:421-428. (Pubitemid 129555303)
19. Schulmann K, ReiserM, Schmiegel W. Colonic cancer and polyps. Best Pract Res Clin Gastroenterol 2002;16:91-114.
20. Half EE, Bresalier RS. Clinical management of hereditary colorectal cancer syndromes. Curr Opin Gastroenterol 2004;20:32-42. (Pubitemid 39117955)
21. Chan AT, Giovannucci EL. Primary prevention of colorectal cancer. Gastroenterology 2010;138:2029-2043.
22. Randi G, Edefonti V, FerraroniM, La Vecchia C, Decarli A. Dietary patterns and the risk of colorectal cancer and adenomas. Nutr Rev 2010;68:389-408.
23. Leonardi T, Vanamala J, Taddeo SS, Davidson LA, Murphy ME, Patil BS,Wang N, Carroll RJ, Chapkin RS, Lupton JR, Turner ND. Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats. Exp Biol Med 2010;235:710-717.
24. Miyamoto S, Yasui Y, Ohigashi H, Tanaka T, Murakami A. Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/dbmice. Chem Biol Interact 2010;183:276-283.
25. Wenzel U, Kuntz S, Brendel MD, Daniel H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res 2000;60:3823-3831. (Pubitemid 32204574)
26. Wenzel U, Kuntz S, Daniel H. NO levels in human preneoplastic colonocytes determine their susceptibility towards anti-neoplastic agents. Mol Pharmacol 2003;64:1494-1502. (Pubitemid 37532238)
27. Preston SL, Leedham SJ, Oukrif D, Deheregoda M, Goodlad RA, Poulsom R, Alison MR,Wright NA, Novelli M. The development of duodenal microadenomas in FAP patients: the human correlate of the Min mouse. J Pathol 2008;214:294-301. (Pubitemid 351212384)
28. Sengupta S, Muir JG, Gibson PR. Does butyrate protect from colorectal cancer? J Gastroenterol Hepatol 2006;21:209-218.
29. Jaiswal AS, Balusu R, Narayan S. Involvement of adenomatous polyposis coli in colorectal tumorigenesis. Front Biosci 2005;10:1118-1134.
30. KobayashiM, HonmaT,MatsudaY, Suzuki Y, NarisawaR, Ajioka Y, Asakura H. Nuclear translocation of beta-catenin in colorectal cancer. Br J Cancer 2000;82:1689-1693. (Pubitemid 30229580)
31. Lim JC, Kania KD, Wijesuriya H, Chawla S, Sethi JK, Pulaski L, Romero IA, Couraud PO, Weksler BB, Hladky SB, Barrand MA. Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells. JNeurochem 2008;106:1855-1865.
32. Tainton KM, Smyth MJ, Jackson JT, Tanner JE, Cerruti L, Jane SM, Darcy PK, Johnstone RW. Mutational analysis of Pglycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux. CellDeathDiffer 2004;11:1028-1037. (Pubitemid 39232362)
33. Schumacher M, Hautzinger A, Rossmann A, Holzhauser S, Popovic D, Hertrampf A, Kuntz S, Boll M, Wenzel U. Chrysin blocks topotecan-induced apoptosis in Caco-2 cells in spite of inhibition of ABC-transporters. Biochem Pharmacol 2010;80:471-479.
34. Lohner K, Schnäbele K, Daniel H, Oesterle D, Rechkemmer G, Göttlicher M, Wenzel U. Flavonoids alter P-gp expression in intestinal epithelial cells in vitro and in vivo. Mol Nutr Food Res 2007;51:293-300. (Pubitemid 47083663)
35. Maier TJ, Janssen A, Schmidt R, Geisslinger G, Grösch S. Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. FASEB J 2005;19:1353-1355. (Pubitemid 41113747)
36. Luo F, Brooks DG, Ye H, Hamoudi R, Poulogiannis G, Patek CE,Winton DJ, Arends MJ. Mutated K-ras (Asp12) promotes tumourigenesis in Apc (Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways. Int J Exp Pathol 2009;90:558-574.